French Court of Appeal SPC decision raises validity concerns
Merck IP right fails test in latest Article 3(a) judgment in case that may make France an even more attractive venue for nullity actions
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.